GSK-2256294

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-2256294
Drug Alias Name2256294GSK-2256294
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpoxide hydratase inhibitors
TargetsEpoxide hydratase
Therapy Area/IndicationsEndocrine System DiseasesObesityPrediabetic State +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University Medical Center
Inactive CompaniesOregon Health And Science UniversityGlaxosmithkline Plc
Active IndicationsObesityPrediabetic StateDiabetes Mellitus +[4] 
Inactive IndicationsEndocrine System DiseasesVascular DiseasesVasospasm, Intracranial +[6] 

Other Information

ATC CodeN/A
Related LinksN/A